| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.6 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.039 | 0.6 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.6 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |